Stroke induces
inflammation that can aggravate brain damage. This work examines whether
interleukin-10 (IL-10) deficiency exacerbates
inflammation and worsens the outcome of permanent
middle cerebral artery occlusion (pMCAO). Expression of
IL-10 and
IL-10 receptor (IL-10R) increased after
ischemia. From day 4, reactive astrocytes showed strong IL-10R immunoreactivity.
Interleukin-10 knockout (IL-10 KO) mice kept in conventional housing showed more mortality after pMCAO than the wild type (WT). This effect was associated with the presence of signs of
colitis in the
IL-10 KO mice, suggesting that ongoing systemic
inflammation was a confounding factor. In a pathogen-free environment,
IL-10 deficiency slightly increased
infarct volume and
neurologic deficits. Induction of proinflammatory molecules in the
IL-10 KO brain was similar to that in the WT 6 hours after
ischemia, but was higher at day 4, while differences decreased at day 7. Deficiency of
IL-10 promoted the presence of more mature phagocytic cells in the ischemic tissue, and enhanced the expression of M2 markers and the T-cell inhibitory molecule CTLA-4. These findings agree with a role of
IL-10 in attenuating local inflammatory reactions, but do not support an essential function of
IL-10 in lesion resolution. Upregulation of alternative immunosuppressive molecules after
brain ischemia can compensate, at least in part, the absence of
IL-10.